Table 2.
Selected Consolidated Framework for the Implementation of Research Questions
| Fellow primary care providers in your clinic… No. (%)a | ||||
|---|---|---|---|---|
| No. (%) | Agree on the goals for lung cancer screening using LDCT | Informed and involved in lung cancer screening using LDCT | Agree on adequate resources (ie, registries and staff to track patients, No. of available CT scanners, etc) to accomplish lung cancer screening using LDCT | Set a high priority on the success of lung cancer screening using LDCT |
| Ruralb | ||||
| Agree | 27 (57%) | 26 (57%) | 18 (39%) | 14 (30%) |
| Neutral | 17 (36%) | 14 (30%) | 20 (43%) | 17 (36%) |
| Disagree | 3 (6%) | 6 (13%) | 7 (15%) | 16 (34%) |
| Not rural | ||||
| Agree | 18 (69%) | 18 (69%) | 11 (44%) | 5 (20%) |
| Neutral | 4 (15%) | 7 (27%) | 7 (28%) | 10 (40%) |
| Disagree | 4 (15%) | 1 (4%) | 7 (28%) | 10 (40%) |
| Lung cancer screening using LDCT has been proven to reduce lung cancer mortality in routine-care settings, No. (%) | ||
|---|---|---|
| No. (%) | How would you rate the strength of the evidence for the [statement above]? | How do you think your colleagues in your clinic would rate the strength of evidence for the [statement above]? |
| Rural | ||
| Weak | 2 (4%) | 3 (6%) |
| Neutral | 5 (10%) | 11 (22%) |
| Strong | 33 (66%) | 24 (48%) |
| Don’t know/NA | 7 (14%) | 12 (24%) |
| Not rural | ||
| Weak | 6 (22%) | 2 (8%) |
| Neutral | 4 (15%) | 10 (38%) |
| Strong | 17 (63%) | 10 (38%) |
| Don’t know/NA | 0 | 4 (15%) |
LDCT = low-dose CT; NA = not applicable.
a
No. (%) of nonmissing data
b
We determined rurality using facility zip codes and Oregon Health Department Rurality Designation Data